14th European Crystal Network (ECN) Workshop—Abstract Proceedings-Reference-Cited by-同舟云学术

14th European Crystal Network (ECN) Workshop—Abstract Proceedings

Published:2024-03-11 Issue:1 Volume:2 Page:60-69
ISSN:2813-4583
Container-title:Gout, Urate, and Crystal Deposition Disease
language:en
Short-container-title:GUCDD

Author:

Lioté Frédéric¹²^ORCID,Perez-Ruiz Fernando³,Ea Hang-Korng¹,Merriman Tony⁴⁵^ORCID,Pascart Tristan⁶^ORCID,So Alexander⁷

Affiliation:

1. Inserm UMR 1132, Hopital Lariboisière Paris, Université Paris Cité, F-75010 Paris, France

2. Feel’Gout, Rheumatology Department, GH Paris Saint-Joseph, F-75014 Paris, France

3. Rheumatology Division, Cruces University Hospital, Vizcaya, Medicine Department, Medicine and Nursing School, University of the Basque Country, 48940 Biskay, Spain

4. Department of Microbiology, University of Otago, 9016 Dunedin, New Zealand

5. Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233, USA

6. Department of Rheumatology, Lille Catholic Hospitals, Saint-Philibert Hospital, University of Lille, F-59000 Lille, France

7. Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland

Abstract

The 14th annual international European Crystal Network was held in Paris on 2 and 3 March 2023. This in-person meeting was attended by 93 participants. Over 40 research abstract submissions were received from investigators, ranging from early career investigators to senior researchers, for plenary oral and poster presentations. Here, we present the accepted, lightly edited abstracts from the presenters consenting to have their work published. We thank and congratulate the presenters for their work and contributions to the meeting.

Funder

G-CAN

Publisher

MDPI AG

Link

https://www.mdpi.com/2813-4583/2/1/6/pdf

Reference9 articles.

1. Workshop report: 4th European crystal network meeting;Merriman;Arthritis Res. Ther.,2013

2. Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study;Maravic;Jt. Bone Spine,2018

3. Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice;Perez;Rheumatol. Ther.,2018

4. Jauffret, C., Ottaviani, S., Latourte, A., Ea, H.K., Graf, S., Lioté, F., Bardin, T., Richette, P., and Pascart, T. (2022). Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres. J. Clin. Med., 11.

5. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: A randomised controlled trial;Doherty;Lancet,2018